UK markets closed

Vericel Corporation (VCEL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
51.23-0.49 (-0.95%)
At close: 04:00PM EDT
51.23 0.00 (0.00%)
After hours: 04:13PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close51.72
Bid51.14 x 200
Ask51.35 x 200
Day's range50.80 - 52.24
52-week range30.18 - 53.14
Avg. volume376,062
Market cap2.49B
Beta (5Y monthly)1.70
PE ratio (TTM)5,123.00
EPS (TTM)0.01
Earnings date01 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est55.57
  • GlobeNewswire

    Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024

    CAMBRIDGE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its second-quarter 2024 financial results on Thursday, August 1, 2024. Vericel’s management will host a conference call and webcast at 8:30 a.m. (ET) to discuss its financial results and business highlights. The live webcast can be accessed on the Investor Relations section of the Vericel we


    Insider Sale: CFO Mara Joseph Anthony Jr Sells 5,000 Shares of Vericel Corp (VCEL)

    On July 12, 2024, Mara Joseph Anthony Jr, Chief Financial Officer of Vericel Corp (NASDAQ:VCEL), executed a sale of 5,000 shares of the company at a price of $50 per share. Following this transaction, the insider now owns 14,436 shares of Vericel Corp. Vericel Corp specializes in the development of patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions.

  • Insider Monkey

    Should You Consider Adding Vericel Corporation (VCEL) to Your Portfolio?

    Next Century Growth Investors, LLC, an investment Management Company, released its “Small Cap Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. The market continued its rally in the first quarter of 2024; it paused in January but resumed its upward trajectory in February and March. In the quarter the small-cap […]